OLIGONUKLEOTIDE MIT EINER PHOSPHORTRITHIOAT-INTERNUKLEOSID-VERKNÜPFUNG

European patent · EP3830102 · In force

Register entry

Publication number
EP3830102
Application number
EP19755294
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 30, 2019
Published
Jun 9, 2021
Granted
Jun 8, 2022
Protection ends at the latest
Jul 29, 2039
Next annual fee due
Jul 31, 2027
IPC classes
C07H 21/00 (2006.01)
A61P 7/00 (2006.01)
A61P 9/00 (2006.01)
Priority
EP 18186679 31.07.2018
PCT application
PCT/EP2019/070406 30.07.2019
PCT publication
WO2020/025563 06.02.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Feb 21, 2025

    Holder’s address changed

    Owner
    Roche Innovation Center Copenhagen A/S, Fremtidsvej 3, 2970 Hørsholm, Denmark → RICC A/S, c/o Roche Diagnostics A/S, Flaskehalsen 17, 4., 1799 Kobenhavn V, Denmark

    Published in Swissreg on 21.02.2025

  4. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  5. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  6. Apr 19, 2023

    Change

    Published in Swissreg on 19.04.2023

  7. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  8. Jun 8, 2022

    Granted

    Published in Swissreg on 08.06.2022

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.